Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease
(2022)
Journal Article
Hampson, C., Evans, W., McKay, L., & Menzies, L. (2022). Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease. EMJ Innovations, https://doi.org/10.33590/emj/21-00181
Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the... Read More about Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease.